Related Experiment Video
Updated: Jul 4, 2026

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
Adenoviral-mediated Rybp expression promotes tumor cell-specific apoptosis
11Medical College of Georgia, Institute of Molecular Medicine and Genetics, Department of Gene Regulation and Cancer Biology, Augusta, GA, USA.
Abstract:
Previous work demonstrated that exogenous expression of Rybp (Ring 1 YY1-binding protein or DEDAF) kills tumor but not non-transformed cells. This tumor-preferential killing activity could be exploited in a gene therapy approach to treat cancer. To test the potential of viral-mediated delivery of Rybp as an anticancer treatment, we generated an adenovirus expressing Rybp (Ad-Rybp). Infection with Ad-Rybp inhibits the proliferation of a range of tumor cell lines, but has no effect on normal cell types. This inhibition of proliferation is the result of the induction of apoptosis, consistent with reports that Rybp regulates apoptosis. Combined Ad-Rybp infection and etoposide treatment resulted in an additive cytotoxic effect in the osteosarcoma cell line U20S. Furthermore, Ad-Rybp infection synergistically cooperates with the death receptor ligand, tumor necrosis factor-alpha, in the induction of apoptosis. These results suggest that Ad-Rybp may have clinical applicability, either alone or in combination with other agents for the treatment of cancer.
Insights
Gene therapy using adenovirus expressing Ring 1 YY1-binding protein (Rybp) shows promise for cancer treatment. Ad-Rybp selectively kills tumor cells by inducing apoptosis, with potential for combination therapies.
Area of Science:
- Oncology
- Gene Therapy
- Molecular Biology
Background:
- Ring 1 YY1-binding protein (Rybp) exhibits tumor-selective cytotoxicity.
- Gene therapy offers a potential strategy for cancer treatment.
Purpose of the Study:
- To evaluate the efficacy of viral-mediated delivery of Rybp as an anticancer agent.
- To assess the therapeutic potential of adenovirus expressing Rybp (Ad-Rybp).
Main Methods:
- Generation of an adenovirus vector for Rybp expression (Ad-Rybp).
- Infection of various tumor and normal cell lines with Ad-Rybp.
- Assessment of cell proliferation, apoptosis induction, and combination effects with etoposide and tumor necrosis factor-alpha.
Main Results:
- Ad-Rybp infection inhibited proliferation in diverse tumor cell lines but not in normal cells.
- Rybp-induced proliferation inhibition resulted from apoptosis.
- Ad-Rybp demonstrated additive cytotoxicity with etoposide and synergistic apoptosis induction with tumor necrosis factor-alpha.
Conclusions:
- Ad-Rybp exhibits tumor-preferential killing activity, suggesting potential as an anticancer therapeutic.
- Ad-Rybp may be clinically applicable as a monotherapy or in combination with other cancer treatments.
More Related Videos
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

